Today: 22 May 2026
ASML stock price rises in premarket after orders beat, 2026 outlook raised, job cuts flagged
28 January 2026
2 mins read

ASML stock price rises in premarket after orders beat, 2026 outlook raised, job cuts flagged

New York, Jan 28, 2026, 04:54 (ET) — Premarket

  • ASML shares climbed roughly 3% in premarket trading following a surge in quarterly bookings that more than doubled
  • Chip equipment maker raised its sales forecast for 2026 and announced a fresh buyback program
  • The company also announced plans to eliminate roughly 1,700 positions

ASML Holding’s U.S.-listed shares jumped 2.9% to $1,454.59 in early trading Wednesday, following the Dutch chip equipment maker’s report of fourth-quarter bookings hitting 13.2 billion euros ($15.8 billion). The company also raised its sales forecast for 2026 and announced plans to cut about 1,700 jobs. Mizuho analyst Kevin Wang attributed the strong orders and outlook to “AI demand for EUV in both logic and DRAM,” a memory chip type. Reuters

Why traders care: ASML controls a critical bottleneck in advanced chipmaking, holding an almost exclusive grip on extreme ultraviolet (EUV) lithography—the machines that etch the tiniest chip details. IMEC CEO Luc Van den Hove highlighted EUV’s “patterning precision, scalability and energy efficiency” as essential for cutting-edge chip production. Reuters reported ASML delivered 44 EUV systems last year. Reuters

The surge in bookings offers a preliminary glimpse into next year’s capital spending, as investors debate whether the AI data-centre buildout is driving a wider upcycle that includes both logic and memory chipmakers. ASML’s order fluctuations often ripple through the broader chip equipment sector, and the market prices them accordingly.

ASML reported fourth-quarter net sales of 9.7 billion euros and net income of 2.8 billion euros. It projected first-quarter 2026 sales between 8.2 billion and 8.9 billion euros. The company raised its 2026 net sales forecast to 34 billion–39 billion euros, expecting gross margins of 51% to 53%. ASML also announced a 2025 dividend of 7.50 euros per share, along with a new share buyback program capped at 12 billion euros through December 31, 2028. CEO Christophe Fouquet said, “We expect 2026 to be another growth year for ASML’s business.” ASML

Still, the optimistic scenario faces hurdles from policy and the economic cycle. Dutch export controls cap shipments of certain machines, aiming to curb China’s access to cutting-edge chipmaking tech. Demand could also sour quickly if customers cut back after an initial surge in AI-driven spending.

Chip equipment stocks gained in U.S. premarket action. Applied Materials jumped 4.1%, Lam Research surged 7.0%, and KLA climbed 4.8%, following the positive signals from ASML’s order report.

Investors are keen to see how much of the order intake translates into immediate shipments versus getting pushed into a longer backlog. They’ll also be tracking if the boost in EUV demand actually lifts margins as the company scales up more complex systems. The recent job cuts complicate matters further: while tighter cost control might help, the risk of execution slips grows when a company reshapes its workforce amid efforts to deliver record numbers of tools.

ASML will host a press conference at 11:00 CET on Wednesday, with an investor call set for 15:00 CET (09:00 ET). Market watchers will be zeroing in on the 2026 demand outlook, the timing of EUV shipments, and how soon restructuring expenses hit operating costs.

Stock Market Today

  • Q1 Earnings Review: Azenta Falls; West Pharmaceutical Leads Drug Development Services Stocks
    May 21, 2026, 9:31 PM EDT. Drug development inputs and services stocks, essential for pharmaceutical research and manufacturing, reported mixed Q1 results. Azenta (NASDAQ:AZTA), specializing in biological sample management, posted disappointing results with $144.8 million revenue, missing estimates and the weakest among peers, causing its share price to drop 23.4% to $17.65. Conversely, West Pharmaceutical Services (NYSE:WST), maker of specialized packaging and delivery devices, delivered a strong quarter with $844.9 million revenue, beating estimates by 8.4%. Overall, the sector's revenues beat consensus by 1.6%, despite an average 2.5% share price decline post-earnings. Tailwinds include growth in biologics and gene therapies, while headwinds feature pricing pressure and regulatory risks.

Latest articles

OpenAI Shares Hype Returns, Still No Ticker in Sight

OpenAI Shares Hype Returns, Still No Ticker in Sight

22 May 2026
OpenAI is preparing to confidentially file for a U.S. IPO, aiming to go public as early as September, sources told Reuters. The move follows a court win against Elon Musk, removing a key legal obstacle. Private-market share prices for OpenAI ranged from $658.94 to $732.38 this month, but no official public price exists. Ordinary investors still cannot buy OpenAI stock on public exchanges.
Estée Lauder Shares Gain as Rumored Deal Fails to Materialize

Estée Lauder Shares Gain as Rumored Deal Fails to Materialize

22 May 2026
Estée Lauder and Spain’s Puig ended merger talks that would have created a $40 billion beauty group. Estée Lauder shares rose about 10% in after-hours trading, closing the regular session at $78.91. The company said it will focus on its turnaround plan and continue reviewing possible acquisitions or divestitures.
WhiteFiber Stock Rips 22% on $160 Million AI Deal. The Test Comes in July

WhiteFiber Stock Rips 22% on $160 Million AI Deal. The Test Comes in July

22 May 2026
WhiteFiber shares jumped 22.2% to $29.55 after announcing a five-year AI compute contract worth over $160 million for a Paris-region deployment using NVIDIA GPU systems. Google Finance showed the stock rising further after hours. The project is backed by planned financing and 12 months of customer prepayments, but funding and execution remain pending. Service is expected to start in July, subject to equipment delivery and acceptance.
Legal & General share price: LGEN ticks up as L&G names new real assets chiefs, Banner Life sale in focus
Previous Story

Legal & General share price: LGEN ticks up as L&G names new real assets chiefs, Banner Life sale in focus

Australia stock market today: ASX 200 snaps winning streak as inflation jolts RBA rate-hike bets
Next Story

Australia stock market today: ASX 200 snaps winning streak as inflation jolts RBA rate-hike bets

Go toTop